THERAPEUTIC POTENTIAL OF CHITRAKADI CHURNA IN THE MANAGE-MENT OF PREDIABETES: A COMPREHENSIVE PHARMACOLOGICAL AND CLINICAL REVIEW
International Ayurvedic Medical Journal · 18.02.2026 · 570
DOI: 10.46607/iamj3114022026 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ayurvedic Medical Journal, online erschienen am 18.02.2026. Verfasst von Hetal M. Patel und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Prediabetes represents a critical, reversible stage in the dysglycemic continuum, characterised by im-paired fasting glucose (IFG) and/or impaired glucose tolerance (IGT), wherein glycemic values exceed physio-logical limits but remain below the diagnostic threshold for diabetes mellitus. From an Ayurvedic perspective, this stage closely resembles the Purvaroopa (prodromal stage) of Prameha, marked by derangement of Kapha and Meda, and the pathological accumulation of Kleda due to Agni Mandya. This narrative review evaluates the therapeutic relevance of Chitrakadi Churna, a classical Samana for-mulation described in Ashtanga Hridaya (Chikitsasthana 12/6), for the prevention and management of prediabe-tes when administered alongside structured lifestyle modification. The formulation comprises Chitraka (Plumba-go zeylanica), Triphala (Emblica officinalis, Terminalia chebula, Terminalia bellirica), Daruharidra (Berberis aristata), and Indrayava (Holarrhena antidysenterica), selected for their Tikta–Kashaya Rasa, Laghu–Ruksha Guna, and Agni-Deepana, Medohara, and Srotoshodhana properties. By correlating classical Rasa Panchaka with contemporary pharmacological evidence—particularly the antidiabetic actions of plumbagin and berberine—this review elucidates the mechanistic basis for how Chitrakadi Churna may improve insulin sensitivity, enhance peripheral glucose utilisation, and delay progression to type 2 diabetes mellitus. The review concludes that standardized Chitrakadi Churna, administered with Koshna Jala for 90 days along with Pathya Ahara–Vihara, offers a rational, holistic, and potentially safe strategy for early metabolic intervention.
Zitieren
APA
Patel, H. M., & Damle, N. (2026). THERAPEUTIC POTENTIAL OF CHITRAKADI CHURNA IN THE MANAGE-MENT OF PREDIABETES: A COMPREHENSIVE PHARMACOLOGICAL AND CLINICAL REVIEW. International Ayurvedic Medical Journal, 570. https://doi.org/10.46607/iamj3114022026
Vancouver
Patel HM, Damle N. THERAPEUTIC POTENTIAL OF CHITRAKADI CHURNA IN THE MANAGE-MENT OF PREDIABETES: A COMPREHENSIVE PHARMACOLOGICAL AND CLINICAL REVIEW. International Ayurvedic Medical Journal. 2026:570. doi:10.46607/iamj3114022026
BibTeX
@article{Patel2026,
author = {Patel, Hetal M. and Damle, Neena},
title = {THERAPEUTIC POTENTIAL OF CHITRAKADI CHURNA IN THE MANAGE-MENT OF PREDIABETES: A COMPREHENSIVE PHARMACOLOGICAL AND CLINICAL REVIEW},
journal = {International Ayurvedic Medical Journal},
year = {2026},
pages = {570},
doi = {10.46607/iamj3114022026}
}
EUVIMED